These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13462142)

  • 1. [Comparative evaluation of the efficiency of sulfanilylbutyl urea & tolyl-sulfonylbutyl urea in the therapy of diabetes mellitus].
    CORSINI G
    G Clin Med; 1957 Apr; 38(4):498-508. PubMed ID: 13462142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral treatment of diabetes mellitus with N-tolyl-sulfonyl-N'-cyclohexyl urea (K-386)].
    JACONO G; BRANCACCIO A; D'ALESSANDRO B; DE LUCA R
    Minerva Med; 1957 Nov; 48(89):3691-7. PubMed ID: 13503854
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new drug with hypoglycemic action in oral therapy of diabetes mellitus: N-tolyl-sulfonyl-N'-cyclohexyl urea (K386)].
    ANGELI G; ALBERINI B
    Minerva Med; 1958 Feb; 49(10):360-4. PubMed ID: 13516784
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various negative aspects of hypoglycemic sulfonyl urea therapy of diabetes mellitus].
    TOLOMELLI E; BACCI L
    Minerva Med; 1958 Apr; 49(31):1473-4. PubMed ID: 13552295
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of metahexamide in the treatment of patients with diabetes mellitus.
    WELLER C; MACAULAY A; LINDER M; TRACY JD
    Metabolism; 1959 Jul; 8(4 Pt 2):672-5. PubMed ID: 13666415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with a new synthetic hypoglycemic drug: N-tolyl-sulfonyl-N'-cyclohexyl urea].
    SCARPIONI L
    Minerva Med; 1958 Apr; 49(31):1468-70. PubMed ID: 13552290
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic action of butyl sulfanilyl urea and N-tolyl-sulfonyl-N'-butyl urea compared in one and the same group of diabetics].
    CORSINI G
    Minerva Med; 1958 Apr; 49(31):1455-6. PubMed ID: 13552279
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of a new synthetic hypoglycemic agent, N-tolyl-sulfonyl-N'-cyclohexyl urea or K 386].
    DEROT M; PIGNARD P; RATHERY M
    Bull Mem Soc Med Hop Paris; 1959 Feb 6-13; 75(5-6):175-9. PubMed ID: 13638799
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of synthetic hypoglycemic agents in juvenile diabetics].
    UHRY P
    Bull Mem Soc Med Hop Paris; 1957 Jun 14-21; 73(20-21):629-30. PubMed ID: 13460706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience & remarks on the therapeutic use of N-tolyl-sulfonyl-N'-cyclohexyl urea].
    TOPI GC; JACOBELLI A; FORCINA G
    Policlinico Med; 1958 Aug; 65(4):240-58 passim. PubMed ID: 13578717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral treatment of diabetes mellitus with sulfonyl urea derivatives].
    VON UEXKULL T
    Ther Ggw; 1958 Aug; 97(8):300-8. PubMed ID: 13580953
    [No Abstract]   [Full Text] [Related]  

  • 12. The oral treatment of diabetes mellitus with N-(4-methylbenzene-sulphonyl)-N-butyl urea (D860).
    MUKHERJEE SK; DE UN; MUKERJI B
    J Indian Med Assoc; 1959 Jun; 32(12):474-8. PubMed ID: 13673164
    [No Abstract]   [Full Text] [Related]  

  • 13. [Criteria for the use of N-[4-methyl-benzolsulfonyl]-N'-butyl urea (D860) in diabetes mellitus].
    MOHNIKE G; ULRICH H; JUTZI E
    Dtsch Med Wochenschr; 1957 Sep; 82(36):1514-5. PubMed ID: 13473480
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of two years of sulfonamide therapy of diabetes mellitus; review].
    GALLETTI F
    Rass Fisiopatol Clin Ter; 1958 May; 30(5):410-26. PubMed ID: 13602141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statistical results on therapy of diabetes mellitus by synthetic hypoglycemic agents].
    UHRY P; MARCEL G; DUIZEND M; VARIN R; COHEN M; TEXIER
    Bull Mem Soc Med Hop Paris; 1957 Jun 14-21; 73(20-21):630-8. PubMed ID: 13460707
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern therapy in diabetes mellitus, insulin, and the oral hypoglycemic agents.
    KIRTLEY WR; PECK FB
    Minn Med; 1958 Sep; 41(9):607-13. PubMed ID: 13577645
    [No Abstract]   [Full Text] [Related]  

  • 17. [N-sulfanilyl-N'-butyl urea (BZ55) therapy of diabetes in patients of pulmonary tuberculosis].
    LENCI E
    Minerva Med; 1958 Apr; 49(31):1482-4. PubMed ID: 13552304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications and contraindications for oral hypoglycemic drug therapy of diabetes mellitus].
    CAVICCHI E
    Athena; 1958; 24(8-10):131-2. PubMed ID: 13607321
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical investigation of hypoglycemic effect of seeds of Azadirachta-inidca in type-2 (NIDDM) diabetes mellitus.
    Waheed A; Miana GA; Ahmad SI
    Pak J Pharm Sci; 2006 Oct; 19(4):322-5. PubMed ID: 17105712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
    MMW Fortschr Med; 2004 Jul; 146(29-30):48-9. PubMed ID: 15540563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.